Week In Review: Cellular Biomedicine In-licenses Cancer Immunotherapy From China
February 15, 2015 at 10:44 AM EST
Deals, trials, financings and approvals in China healthcare sector this week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.